Company news

Curis, Inc. news in 2026

Curis, Inc.'s news releases, calls and decks from 2026, newest first.

View company

Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors

October 16, 2026

Curis, Inc. Announces Pricing of $5.6 Million Public Offering

August 13, 2026

Curis Doses First Five Patients in TakeAim CLL Study

July 30, 2026

Curis Announces Positive Emavusertib Update

July 22, 2026

Curis Consents First Six Patients in TakeAim CLL Study

July 6, 2026

Curis Announces Eleven Active Clinical Sites in TakeAim CLL Study, Reaffirms Patient Dosing Guidance, and Reports Stockholder Approval of Reverse Stock Split

June 26, 2026

Curis Provides First Quarter 2026 Business Update

May 12, 2026

Curis to Report First Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on May 12, 2026

May 5, 2026

Curis Provides Fourth Quarter 2025 Business Update

March 19, 2026

Curis to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call and Webcast on March 19, 2026

March 12, 2026

Curis Announces Closing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

January 9, 2026

Curis Announces Pricing of Private Placement Totaling up to $80.8 Million in Gross Proceeds

January 7, 2026

Calls in 2026

Decks in 2026